Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience

C Mari Aparici, SC Behr, Y Seo, RK Kelley… - Molecular …, 2017 - journals.sagepub.com
While cross-sectional imaging with computed tomography (CT) and magnetic resonance
imaging is the primary method for diagnosing hepatocellular carcinoma (HCC), they provide …

68Ga-FAPI and 18F-FDG PET/CT in evaluation of primary and metastatic lesions in late-stage hepatocellular carcinoma

M Wu, X Wang, X Yang, Y Wang, H Zhao, L Huo - 2022 - Soc Nuclear Med
2373 Introduction: 68 Ga-FAPI PET has been proposed for more sensitive detection of
primary hepatocellular carcinoma (HCC) than 18 F-FDG PET. This study aimed to compare …

The emerging role of positron emission tomography in hepatocellular carcinoma

SR Dubash, OA Idowu, R Sharma - Hepatic oncology, 2015 - Future Medicine
Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality worldwide. HCC a
heterogeneous disease occurring on the background of cirrhosis. The presence of cirrhosis …

Recent advances in PET probes for hepatocellular carcinoma characterization

L Filippi, O Schillaci, O Bagni - Expert Review of Medical Devices, 2019 - Taylor & Francis
ABSTRACT Introduction: Positron Emission Tomography (PET) with 18F-
fluorodeoxyglucose (FDG) presents some limitations for imaging of hepatocellular …

[HTML][HTML] 68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma

H Wang, W Zhu, S Ren, Y Kong, Q Huang… - Frontiers in …, 2021 - frontiersin.org
Background Fibroblast activation protein (FAP) is commonly expressed in activated stromal
fibroblasts in various epithelial tumours. Recently, 68Ga-FAPI-04 has been used for tumour …

Glypican-3–targeted 89Zr PET imaging of hepatocellular carcinoma

JG Sham, FM Kievit, JR Grierson… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Hepatocellular carcinoma (HCC) is a devastating malignancy in which imperfect imaging
plays a primary role in diagnosis. Glypican-3 (GPC3) is an HCC-specific cell surface …

Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma

C Ho, S Chen, DWC Yeung… - Journal of Nuclear …, 2007 - Soc Nuclear Med
We have reported previously that 11C-acetate (11C-ACT) PET was complementary to 18F-
FDG PET in the evaluation of primary hepatocellular carcinoma (HCC) in relation to the …

Comparison of 11C‐acetate positron emission tomography and 67Gallium citrate scintigraphy in patients with hepatocellular carcinoma

S Li, M Beheshti, M Peck‐Radosavljevic… - Liver …, 2006 - Wiley Online Library
Aims: Nuclear imaging may have an increasing role in the diagnosis of hepatocellular
carcinoma (HCC). The aim of this study was to compare prospectively the Gallium‐67 citrate …

The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma

M Sørensen, K Frisch, D Bender, S Keiding - European journal of nuclear …, 2011 - Springer
Purpose The aim of the study was to evaluate the feasibility of using the hepatocyte-specific
positron emission tomography (PET) tracer 2-[18 F] fluoro-2-deoxy-D-galactose (FDGal) as a …

[HTML][HTML] 68Ga-PSMA PET/CT versus 18F-FDG PET/CT for imaging of hepatocellular carcinoma

C Gündoğan, N Ergül, MS Çakır… - Molecular Imaging …, 2021 - ncbi.nlm.nih.gov
Objectives: This study aimed to compare the metabolic parameters obtained from 18 fluorine-
fluorodeoxyglucose (18 F-FDG) positron emission tomography/computed tomography …